Biologics

Analysis of biologics, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.

Rows of orange pill bottles with an opened bottle and two pills in the middle
Pharma

Say goodbye to trypanophobia—this biotech is trying to turn injectable drugs into pills

CEO Talat Imran says RaniPill could get its first approval in three years.

Maia Anderson
A blonde boy with oversized glasses holds a molecule model.
Pharma

The $300b market for biologic drugs is bound to get hotter

These drugs have “changed what we can do with medicine.”

Maia Anderson

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew